Revenue breakdown: Health Care Specialty Pharmacy (33.8%), Health Care Patient Service (32.6%), Fee For Service (21.4%).
8-K
The Oncology Institute, Inc. furnished an Investor Presentation dated March 13, 2026, as Exhibit 99.1 under Item 7.01, which is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934. This presentation provides investor-focused information.
$310M
Market Cap
$49M
Revenue
-$6M
Net Income
Employees825
Fundamentals
How The Business Makes Money
Revenue by Segment
Health Care Specialty Pharmacy33.8%($449M)
Health Care Patient Service32.6%($434M)
Fee For Service21.4%($285M)
Capitated Revenue11.2%($149M)
Clinical Research Trials And Other Revenue1%($13M)